Refine your search
311 results found
Smart & Biggar | Canada | 24 Feb 2023
Marketing and advertising tips, traps and trends for 2023
Advertisers should be cautious of misleading advertising – particularly in relation to dark patterns, drip pricing, greenwashing and adequate disclosure of material connection when influencers are used. They should also be aware of developments in accessibility requirements, healthwashing concerns and the gatekeeping power of online platforms. This article highlights key tips, traps and......
Smart & Biggar | Canada | 27 Jul 2022
Updates to Health Canada's regulatory initiatives for 2022-2024 and amendments to Food and Drug Regulations (Exports and Transhipments of Drugs)
Health Canada has updated its Forward Regulatory Plan: 2022-2024, providing information on the regulatory initiatives that Health Canada aims to propose or finalise over the next two years. Health Canada has also updated its Regulatory Stock Review Plan: 2022-2024, which is a public list and description of planned reviews of regulations that Health Canada is proposing within a two-year......
Gowling WLG | Canada | 21 Jul 2022
Judging a food by its cover: Health Canada publishes front-of-package (FOP) nutrition labelling regulations for foods high in saturated fat, sodium and/or sugar
On July 20, 2022, Health Canada published amendments to the Food and Drug Regulations ("FDR") creating a requirement for prepackaged foods whose…
Gowling WLG | Canada | 21 Jul 2022
A seat at the table at last: Supplemented foods added to the Food and Drugs Regulations
Health Canada published amendments to the Food and Drug Regulations ("FDR") on July 20, 2022, adding supplemented foods as a category of food that can…
Smart & Biggar | Canada | 20 Apr 2022
New guidance documents and regulatory amendments regarding therapeutic product shortages
In response to the covid-19 pandemic, the minister of health made interim orders pursuant to the Food and Drugs Act to address the significant risk to health posed by shortages in 2020 and 2021. In anticipation of the expiry of Interim Order No. 2, the Regulations Amending Certain Regulations Concerning Drugs and Medical Devices (Shortages) (the Regulations) were promulgated in 2021. Various......
Smart & Biggar | Canada | 27 Oct 2021
Regulatory amendments provide permanent measures to address therapeutic product shortages
The Regulations Amending Certain Regulations Concerning Drugs and Medical Devices (Shortages) were recently published in Part II of the Canada Gazette. These amendments are intended to provide Health Canada with permanent regulatory tools to help prevent or alleviate therapeutic product shortages.
CPST Intellectual Property | Canada | 16 Jun 2020
Data Protection for Innovative Drugs in Canada
Canada, like many other countries, has a system of data protection for innovative drugs. The purpose of this article is to provide an overview of the…
Stikeman Elliott LLP | Canada, Mexico, USA | 18 Feb 2020
Update on the Canada-United States-Mexico Agreement (CUSMA)
On December 10, 2019, the Governments of Canada, the United States and Mexico executed the Protocol of Amendment to the Agreement between Canada, the…
Bristows | European Union, United Kingdom | 13 Feb 2020
CBD - Could be done for?
Today the Food Standards Agency (FSA) announced that Products Containing cannabidiol (CBD) Extracts must be the subject of a valid application with…
McDermott Will & Emery | USA | 7 Jun 2019
Learnings from the FDA Hearing on Cannabis and Cannabis-Derived Compounds
On Friday May 31, 2019, the Food and Drug Administration (FDA) held a public hearing on the topic of cannabis or cannabis-derived compounds. The FDA…
